Bejon P


197 results

Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.Todryk SM, Bejon P, Mwangi T, Plebanski M, Urban B, Marsh K, Hill AV, Flanagan KL
PLoS One, (2008). 3:e2027

Taking social relationships seriously: lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast.Gikonyo C, Bejon P, Marsh V, Molyneux S
Soc Sci Med, (2008). 67:708-20

Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.Agak GW, Bejon P, Fegan G, Gicheru N, Villard V, Kajava AV, Marsh K, Corradin G
Vaccine, (2008). 26:1963-71

Helminth infection and eosinophilia and the risk of Plasmodium falciparum malaria in 1- to 6-year-old children in a malaria endemic area.Bejon P, Mwangi TW, Lowe B, Peshu N, Hill AV, Marsh K
PLoS Negl Trop Dis, (2008). 2:e164

Incorporating a quiz into informed consent processes: qualitative study of participants' reactions.Molyneux S, Gikonyo C, Marsh V, Bejon P
Malar J, (2007). 6:145

Clearing asymptomatic parasitaemia increases the specificity of the definition of mild febrile malaria.Bejon P, Mwangi T, Lowe B, Peshu N, Hill AV, Marsh K
Vaccine, (2007). 25:8198-202

The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum.Bejon P, Mwacharo J, Kai O, Todryk S, Keating S, Lowe B, Lang T, Mwangi TW, Gilbert SC, Peshu N, Marsh K, Hill AV
J Immunol, (2007). 179:4193-201

Defining childhood severe falciparum malaria for intervention studies.Bejon P, Berkley JA, Mwangi T, Ogada E, Mwangi I, Maitland K, Williams T, Scott JA, English M, Lowe BS, Peshu N, Newton CR, Marsh K
PLoS Med, (2007). 4:e251

Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Bejon P, Ogada E, Mwangi T, Milligan P, Lang T, Fegan G, Gilbert SC, Peshu N, Marsh K, Hill AV
PLoS One, (2007). 2:e707

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Bejon P, Mwacharo J, Kai O, Mwangi T, Milligan P, Todryk S, Keating S, Lang T, Lowe B, Gikonyo C, Molyneux C, Fegan G, Gilbert SC, Peshu N, Marsh K, Hill AV
PLoS Clin Trials, (2006). 1:e29

Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals.Bejon P, Keating S, Mwacharo J, Kai OK, Dunachie S, Walther M, Berthoud T, Lang T, Epstein J, Carucci D, Moris P, Cohen J, Gilbert SC, Peshu N, Marsh K, Hill AV
Infect Immun, (2006). 74:6331-8

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.Bejon P, Kai OK, Mwacharo J, Keating S, Lang T, Gilbert SC, Peshu N, Marsh K, Hill AV
Eur J Immunol, (2006). 36:2264-72

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.Bejon P, Mwacharo J, Kai OK, Todryk S, Keating S, Lang T, Gilbert SC, Peshu N, Marsh K, Hill AV
Vaccine, (2006). 24:4709-15

Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.Bejon P, Peshu N, Gilbert SC, Lowe BS, Molyneux CS, Forsdyke J, Lang T, Hill AV, Marsh K
Clin Infect Dis, (2006). 42:1102-10

Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya.Bejon P, Mwangi I, Ngetsa C, Mwarumba S, Berkley JA, Lowe BS, Maitland K, Marsh K, English M, Scott JA
J Antimicrob Chemother, (2005). 56:232-5

B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area.Dorfman JR, Bejon P, Ndungu FM, Langhorne J, Kortok MM, Lowe BS, Mwangi TW, Williams TN, Marsh K
J Infect Dis, (2005). 191:1623-30

Malaria.Maitland K, Bejon P, Newton CR
Curr Opin Infect Dis, (2003). 16:389-95